Is Rossari Biotech a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Rossari Biotech Ltd is a good quality company .

Is Rossari Biotech undervalued or overvalued?

The key valuation ratios of Rossari Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Rossari Biotech share price return in the past 10 years?

Data is not available for this company

Is Rossari Biotech a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Rossari Biotech Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Rossari Biotech Ltd - Stock Valuation and Financial Performance

Name: Rossari Biotech
Brand: Rossari Biotech

BSE: 543213 | NSE: ROSSARI | Chemicals | Small Cap

Place order

Rossari Biotech Share Price

₹772.05 -27.00 -3.38%
as on 18-Nov'24 16:59

10 Year X-Ray of Rossari Biotech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	10.7%	10.3%	26.4%	40.4%	54.4%	37.9%	28.8%	24.4%	18.5%	18.4%	-
Value Creation Index ⓘ	-0.2	-0.3	0.9	1.9	2.9	1.7	1.1	0.8	0.3	0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	171	179	233	292	516	600	709	1,483	1,656	1,831	1,924
Sales YoY Gr.	-	4.4%	30.6%	25%	76.9%	16.3%	18.2%	109.1%	11.7%	10.6%	-
Adj EPS ⓘ	0.8	0.7	3.3	5.9	9.5	12.6	15.3	16.3	18.3	22.6	25.1
YoY Gr.	-	-7.9%	364.3%	81.9%	60.1%	33.1%	21.8%	6%	12.9%	23.1%	-
BVPS (₹) ⓘ	9.7	10.3	13.5	19.5	25.6	56.4	78.3	145.7	165.3	189	201.9
Adj Net Profit ⓘ	3.7	3.4	15.7	28.6	45.8	63.9	79.6	89.5	101	125	139
Cash Flow from Ops. ⓘ	8.1	25.7	7.2	23.6	71.2	56.8	47.8	29.4	152	43.3	-
Debt/CF from Ops. ⓘ	5.4	0.9	3.1	0.9	0.1	1.2	0	0.3	0.5	2.5	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	30.1%	28.8%	37.2%	10.6%
Adj EPS ⓘ	45.8%	19%	13.8%	23.1%
BVPSⓘ	39.1%	49.2%	34.1%	14.4%
Share Price	-	-	-18.7%	6.2%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	7.7	7	27.3	35.8	42	31.1	22.9	14.7	11.8	12.7	12.8
Op. Profit Mgn % ⓘ	8.6	7	10.4	15.3	15.1	17.5	17.4	11.9	13	13.3	13.4
Net Profit Mgn % ⓘ	2.2	1.9	6.7	9.8	8.9	10.7	11.2	6	6.1	6.8	7.2
Debt to Equity ⓘ	0.9	0.5	0.3	0.2	0	0.2	0	0	0.1	0.1	0.1
Working Cap Days ⓘ	153	132	107	109	107	140	163	134	166	189	82
Cash Conv. Cycle ⓘ	81	62	42	45	24	13	29	46	68	79	42

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 37.16%

Net Profit is growing at healthy rate in last 3 years 13.76%

Sales growth is good in last 4 quarters at 14.44%

Return on Equity has declined versus last 3 years average to 12.80%

Latest Financials - Rossari Biotech Ltd.

	Standalone	Consolidated
TTM EPS (₹)	18.7	25.1
TTM Sales (₹ Cr.)	1,249	1,924
BVPS (₹.) ⓘ	182.8	201.9
Reserves (₹ Cr.) ⓘ	1,001	1,107
P/BV ⓘ	4.37	3.96
PE ⓘ	42.75	31.88

From the Market
52 Week Low / High (₹)	657.80 / 966.00
All Time Low / High (₹)	536.10 / 1620.60
Market Cap (₹ Cr.)	4,423
Equity (₹ Cr.)	11.1
Face Value (₹)	2
Industry PE ⓘ	56.4

Management X-Ray of Rossari Biotech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Rossari Biotech

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Rossari Biotech

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	171	179	233	292	516	600	709	1,483	1,656	1,831
Operating Expenses ⓘ	156	166	209	247	439	495	586	1,307	1,441	1,587
Manufacturing Costs	4	4	6	3	13	14	21	38	49	64
Material Costs	123	131	166	197	339	372	462	1,108	1,171	1,294
Employee Cost	11	12	14	20	28	37	42	68	99	103
Other Costs ⓘ	18	20	23	28	59	73	61	93	123	127
Operating Profit ⓘ	15	13	24	45	78	105	123	176	215	243
Operating Profit Margin (%)	8.5%	7.0%	10.4%	15.3%	15.0%	17.5%	17.3%	11.9%	13.0%	13.3%
Other Income ⓘ	0	0	1	1	1	4	9	19	14	14
Interest ⓘ	5	4	2	1	3	4	3	13	22	19
Depreciation ⓘ	5	5	4	5	12	17	23	48	63	60
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	5	5	19	40	63	88	107	136	144	178
Tax ⓘ	1	1	3	11	18	23	27	39	37	47
Profit After Tax	4	3	16	29	46	65	80	98	107	131
PAT Margin (%)	2.2%	1.9%	6.7%	9.9%	8.8%	10.9%	11.3%	6.6%	6.5%	7.1%
Adjusted EPS (₹)	0.8	0.7	3.3	6.0	9.4	12.9	15.5	17.7	19.5	23.7
Dividend Payout Ratio (%)	6%	0%	0%	30%	5%	4%	3%	3%	3%	2%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	47	50	65	94	124	286	407	802	912	1,044
Share Capital ⓘ	4	4	4	4	4	10	10	11	11	11
Reserves ⓘ	42	46	61	90	119	276	396	791	901	1,033
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	39	22	22	20	4	61	0	0	64	96
Long Term Debt	9	7	2	1	1	34	0	0	35	33
Short Term Debt	30	15	20	19	3	27	0	0	29	63
Trade Payables	18	28	32	40	106	97	131	186	181	219
Others Liabilities ⓘ	10	8	5	11	49	80	107	429	415	465
Total Liabilities ⓘ	114	109	124	166	283	525	645	1,417	1,572	1,825
Fixed Assets
Gross Block	67	38	76	88	86	122	234	704	743	791
Accumulated Depreciation	30	0	38	43	12	29	53	97	158	213
Net Fixed Assetsⓘ	38	38	38	45	74	94	181	607	585	578
CWIP ⓘ	7	8	8	10	3	22	0	1	16	47
Investmentsⓘ	0	0	0	7	0	18	0	36	51	63
Inventories	31	25	24	35	55	58	95	190	188	282
Trade Receivables	30	31	47	60	86	94	144	305	354	425
Cash Equivalents	1	3	2	1	6	127	88	52	124	30
Others Assetsⓘ	7	5	5	8	59	112	135	225	253	399
Total Assets ⓘ	114	109	124	166	283	525	645	1,417	1,572	1,825

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	8	26	7	24	71	57	48	29	152	43
PBT ⓘ	5	5	19	40	63	88	107	136	144	178
Adjustment ⓘ	9	7	6	6	17	20	21	55	83	76
Changes in Working Capital ⓘ	-5	13	-14	-11	11	-31	-48	-112	-28	-157
Tax Paid ⓘ	-1	-1	-3	-11	-20	-20	-31	-50	-48	-54
Cash Flow From Investing Activity ⓘ	-2	-5	-6	-20	-36	-190	-37	-299	-181	-103
Capex	-2	-5	-6	-14	-44	-76	-56	-36	-31	-126
Net Investments	0	0	0	0	7	-18	14	-6	-14	-9
Others ⓘ	0	0	0	-7	1	-96	5	-257	-136	32
Cash Flow From Financing Activityⓘ	-6	-19	-2	-5	-29	157	-25	292	61	16
Net Proceeds from Shares ⓘ	0	0	0	0	0	100	43	302	4	4
Net Proceeds from Borrowing ⓘ	0	0	0	0	-1	39	-34	0	45	-12
Interest Paid ⓘ	-5	-3	-2	-1	-2	-3	-4	-2	-6	-16
Dividend Paid ⓘ	0	0	0	0	-11	-3	-3	-3	-3	-3
Others ⓘ	-2	-17	0	-4	-16	24	-27	-5	21	43
Net Cash Flow ⓘ	0	2	0	-2	6	23	-14	22	32	-44

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	8.18	6.99	27.27	36.33	41.88	31.83	23.11	16.17	12.52	13.36
ROCE (%)	10.7	10.3	26.4	40.37	54.4	37.93	28.81	24.37	18.48	18.39
Asset Turnover Ratio	1.43	1.6	2	2.06	2.3	1.49	1.22	1.45	1.11	1.08
PAT to CFO Conversion(x)	2	8.67	0.44	0.83	1.54	0.88	0.6	0.3	1.42	0.33
Working Capital Days
Receivable Days	62	62	61	66	51	54	61	55	72	77
Inventory Days	78	58	38	36	32	34	39	35	42	47
Payable Days	68	65	66	67	79	100	90	52	57	56

Rossari Biotech Ltd Stock News

Rossari Biotech Ltd FAQs

What is the share price of Rossari Biotech?

Company share prices are keep on changing according to the market conditions. The closing price of Rossari Biotech on 18-Nov-2024 16:59 is ₹772.0.

What is the market cap of Rossari Biotech?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-Nov-2024 16:59 the market cap of Rossari Biotech stood at ₹4,423.2.

What is the P/E ratio of Rossari Biotech?

The latest P/E ratio of Rossari Biotech as of 18-Nov-2024 16:59 is 42.75.

What is the P/B ratio of Rossari Biotech?

The latest P/B ratio of Rossari Biotech as of 18-Nov-2024 16:59 is 4.37.

What is the 52-week high and low of Rossari Biotech?

The 52-week high of Rossari Biotech is ₹966.0 and the 52-week low is ₹657.8.

What is the TTM revenue of Rossari Biotech?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rossari Biotech is ₹1,249 ( Cr.) .

About Rossari Biotech Ltd

The company was initially incorporated as Rossari Labtech on March 6, 2003, as a partnership firm under the Indian Partnership Act, 1932, pursuant to a certificate of registration dated June 22, 2003, issued by the Registrar of Firms, Mumbai. The name of the partnership firm was changed to Rossari Biotech on December 5, 2003 and further the firm converted into a joint stock company on August 10, 2009, under part IX of the Companies Act, 1956 as Rossari Biotech Limited with a certificate of incorporation granted by the Registrar of Companies, Maharashtra at Mumbai (RoC). The company received its certificate of commencement of business on August 13, 2009.

Business area of the company

The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company’s business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products.

The company is the leading manufacturer of acrylic polymers in India and manufactures many products for its customers in the soaps and detergent, paints, inks and coatings, ceramics and tiles, water treatment chemicals and pulp and paper industries. It also manufacture institutional cleaning chemical formulations for hospitality, facility management, airports, corporates, food service, commercial laundry, malls, multiplexes, educational sector, places of worship etc. It is in advanced stages of expanding its home, personal care and performance product portfolio to water treatment formulations, specialty formulation for breweries as well as dairies. Besides, the company provides specialty chemicals for the entire value-chain of the textile industry starting from fiber, yarn to fabric, wet processing and garment processing. The company has also diversified into animal health and nutrition and currently supply poultry feed supplements and additives, pet grooming and pet treats including for weaning, infants and adult pets.

Major Events & Milestones:

2003: The company’s Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India.
2004: Established first manufacturing facility at Silvassa.
2009: Conversion of partnership firm into company.
2009: Incorporation of company.
2009: Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research.
2010: Forayed into animal health and nutrition products.
2013: Forayed into HPPC products.
2014: The company’s Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari.
2015: Lease granted by GIDC to company for setting up manufacturing facility at Dahej.
2017: The Food Safety Management System of Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015.
2018: Entered into an exclusive purchasing agreement with Hindustan Unilever.
2020: Completion of the Pre-IPO Placement.

Awards & accreditations:

2009: The erstwhile Hon’ble Union Finance Minister Pranab Mukherjee awarded ‘Corp EXCEL 2008– National mSME’ form a list of 27000 companies.
2010: Frost & Sullivan awarded ‘Customer Value Enhancement for Industrial Enzymes Market’.
2011: The Council for Fair Business Practices awarded ‘CFBP – Jamnalal Bajaj Uchit Vyavahar Puraskar for Fair Business Practices’.
2017: The India SME Forum awarded at the India SME 100 Awards for ‘scoring in the top 100 in the overall evaluation of Financial & Non - Financial Parameters amongst 33102 nominations’.
2018: Arvind awarded ‘Star Performer Award 2018’ in the Dye & Chemicals Category.